Thrombolytic drugs for cardiac arrest: a review of the clinical effectiveness

Record ID 32014000222
Authors' recommendations: Higher quality controlled trials indicate that the use of thrombolytic drugs does not improve survival to hospital discharge and 30-day mortality, and increases the risk of bleeding for patients experiencing a cardiac arrest.
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Heart Arrest
  • Thrombolytic Therapy
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.